Summary by Moomoo AI
CONXINO BIO CO., LTD. (THE “COMPANY”) ISSUED AN OVERSEAS REGULATORY NOTICE ON APRIL 30, 2024, MENTIONING IN THE ANNOUNCEMENT THAT THE COMPANY HAS PUBLISHED A RESPONSE TO THE INFORMATION DISCLOSURE REGULATORY INQUIRY ON THE WEBSITE OF THE SHANGHAI STOCK EXCHANGE TO THE ACCOUNTING FIRM OF DCHIN HUAYONG (SPECIAL GENERAL PARTNERSHIP) REGARDING THE 2023 ANNUAL REPORT. This reply is for investor reference only and is published by Chairman Xuefeng YU on behalf of the Board of Directors. The members of the Board of Directors include Executive Directors Dr. Xuefeng YU, Dr. Shou Bai CHAO and Ms. Wang Jing; Ms. Leung Wing Yu, Non-Executive Director; and Mr. Kwai Shuifa, Mr. Liu Jianzhong and Mr. Zhang Yiu Leung.